Literature DB >> 15474001

Type II phosphoinositide 5-phosphatases have unique sensitivities towards fatty acid composition and head group phosphorylation.

Annette C Schmid1, Helen M Wise, Christina A Mitchell, Robert Nussbaum, Rüdiger Woscholski.   

Abstract

The catalytic properties of the type II phosphoinositide 5-phosphatases of Lowe's oculocerebrorenal syndrome, INPP5B, Synaptojanin1, Synaptojanin2 and SKIP were analysed with respect to their substrate specificity and enzymological properties. Our data reveal that all phosphatases have unique substrate specificities as judged by their corresponding KM and VMax values. They also possessed an exclusive sensitivity towards fatty acid composition, head group phosphorylation and micellar presentation. Thus, the biological function of these enzymes will not just be determined by their corresponding regulatory domains, but will be distinctly influenced by their catalytic properties as well. This suggests that the phosphatase domains fulfil a unique catalytic function that cannot be fully compensated by other phosphatases. Copyright 2004 Federation of European Biochemical Societies

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474001     DOI: 10.1016/j.febslet.2004.08.052

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  60 in total

1.  Use of RNA interference in Drosophila S2 cells to identify host pathways controlling compartmentalization of an intracellular pathogen.

Authors:  Luisa W Cheng; Julie P M Viala; Nico Stuurman; Ursula Wiedemann; Ronald D Vale; Daniel A Portnoy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

2.  A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.

Authors:  Yuxin Mao; Daniel M Balkin; Roberto Zoncu; Kai S Erdmann; Livia Tomasini; Fenghua Hu; Moonsoo M Jin; Michael E Hodsdon; Pietro De Camilli
Journal:  EMBO J       Date:  2009-06-18       Impact factor: 11.598

Review 3.  Features of the Phosphatidylinositol Cycle and its Role in Signal Transduction.

Authors:  Richard M Epand
Journal:  J Membr Biol       Date:  2016-06-08       Impact factor: 1.843

Review 4.  The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.

Authors:  Maria Antonietta De Matteis; Leopoldo Staiano; Francesco Emma; Olivier Devuyst
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

Review 5.  The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.

Authors:  Ana Raquel Ramos; Somadri Ghosh; Christophe Erneux
Journal:  J Lipid Res       Date:  2018-09-07       Impact factor: 5.922

Review 6.  Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL.

Authors:  Michelle Pirruccello; Pietro De Camilli
Journal:  Trends Biochem Sci       Date:  2012-02-28       Impact factor: 13.807

7.  A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway.

Authors:  Kai S Erdmann; Yuxin Mao; Heather J McCrea; Roberto Zoncu; Sangyoon Lee; Summer Paradise; Jan Modregger; Daniel Biemesderfer; Derek Toomre; Pietro De Camilli
Journal:  Dev Cell       Date:  2007-09       Impact factor: 12.270

8.  Tails wagging the dogs: On phosphoinositides and their fatty acyl moieties.

Authors:  Ingo Heilmann
Journal:  Plant Signal Behav       Date:  2008-10

9.  The 5-phosphatase OCRL mediates retrograde transport of the mannose 6-phosphate receptor by regulating a Rac1-cofilin signalling module.

Authors:  Vanessa A van Rahden; Kristina Brand; Juliane Najm; Joerg Heeren; Suzanne R Pfeffer; Thomas Braulke; Kerstin Kutsche
Journal:  Hum Mol Genet       Date:  2012-08-19       Impact factor: 6.150

Review 10.  At the poles across kingdoms: phosphoinositides and polar tip growth.

Authors:  Till Ischebeck; Stephan Seiler; Ingo Heilmann
Journal:  Protoplasma       Date:  2009-12-20       Impact factor: 3.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.